AGP Executive Report
Last update: 9 hours agoEMA Approvals: The EMA backed new oral options for hard-to-treat conditions, including Lynavoy (linerixibat) for PBC itch and Icotyde (icotrokinra) for plaque psoriasis, signaling a shift toward easier-to-use therapies. Health & Behaviour: A pan-European study found psychological and contextual barriers can slow prescribing of new neurodegenerative treatments, even when clinical data is strong. Energy Routes: Syria has become a key overland node for moving 2.1m tonnes of Iraqi fuel oil to Europe since April, with lorry volumes reportedly rising from 10 to 1,000 a day. MarCom/Media Pricing: New analysis maps huge video editing rate gaps—same-skill editors charge about $25/hr in Manila versus $90+/hr in New York—useful for agencies planning production budgets. Luxury Wellness Marketing: MICRO by The Fix is staging a Cannes residency at Hôtel Martinez before bringing the concept to Chelsea, underlining how hospitality and brand activations keep converging. Wildfire Risk: London faces an “exceptionally high” wildfire threat this week as temperatures hit 33C, with knock-on pressure for tourism and outdoor events. Defence Tech: DroneShield secured A$23.2m in European counter-drone contracts, while XTEND completed Atlas integration to expand autonomous robotic and tactical comms coverage across Europe.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![Perspective Therapeutics Receives European Orphan Medicinal Product Designation for [212Pb]VMT-α-NET in GEP-NETs](https://2c717466dc25cd7041c9-8eeda6a8ca964cf210ed223dbc947813.ssl.cf2.rackcdn.com/18578399-652798331-persp-jpg-100x21.jpeg)
